查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1643897

全球诊断皮肤科设备市场 - 2025-2033

Global Diagnostic Dermatology Equipment Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球诊断皮肤科设备市场在2024年达到108亿美元，预计2033年将达到224亿美元，2025-2033年预测期间复合年增长率为5.9%。

诊断皮肤科设备市场是一个至关重要的领域，它使用各种工具和技术来识别、监测和评估皮肤病，如皮肤癌、牛皮癣、湿疹和色素沉着障碍。这些设备（如皮肤镜、反射共焦显微镜和光学相干断层扫描）可提供准确、非侵入性的早期诊断，进而改善患者的治疗效果。该市场由人工智慧整合和远端皮肤科解决方案等技术进步推动。该行业在皮肤病护理中发挥关键作用，弥合了传统方法与现代、数位和人工智慧驱动的解决方案之间的差距。

市场动态：

驱动程式和限制

皮肤病的盛行率不断增加

痤疮、牛皮癣、湿疹和黑色素瘤等皮肤疾病的日益流行推动了诊断皮肤科设备的全球市场，这些疾病由于污染、生活方式的改变和长时间暴露在阳光下等因素而变得更加普遍。世界卫生组织报告称，皮肤病每年影响数百万人，导致对皮肤镜、影像系统和活检设备等先进诊断工具的需求。人们对皮肤健康和常规皮肤病检查的认识不断增强，进一步鼓励了这些设备的采用，确保了市场的成长。

例如，根据美国皮肤病学会的数据，痤疮是美国最常见的皮肤病，每年影响多达 5,000 万美国人。存在不同类型的痤疮，因此一刀切的方法并不适用。经过委员会认证的皮肤科医生可以根据皮肤类型和痤疮类型进行诊断并确定适当的治疗方法。有多种治疗方法可供选择，包括口服药物、外用药物、非处方药和处方药。痤疮通常始于青春期并影响青少年和年轻人，但可以发生在生命的任何阶段。成人痤疮持续增加，影响高达 15% 的女性。大约 85% 12-24 岁的人会出现轻微痤疮。

皮肤科诊断设备成本高昂

包括皮肤镜、共焦显微镜和成像系统在内的诊断皮肤科设备的高成本是市场成长的主要障碍，特别是在低收入和中等收入地区。这些先进的工具前期费用昂贵，因此较小的诊所和医疗机构不太容易使用它们。维护和营运费用也增加了财务负担，进一步限制了它们的采用。在医疗保健预算有限或不优先考虑皮肤科服务的地区，这个问题尤其成问题。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

  • 影响因素
    • 司机
      • 皮肤病的盛行率不断增加
    • 限制
      • 皮肤科诊断设备成本高昂
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：依产品类型

  • 影像设备
  • 显微镜设备
  • 切片装置
  • 其他诊断设备

第 7 章：按技术

  • 数位影像
  • 人工智慧驱动的诊断工具
  • 光学成像
  • 分子影像

第 8 章：按申请

  • 皮肤癌诊断
  • 牛皮癣诊断
  • 湿疹诊断
  • 痤疮诊断
  • 色素沉着疾病诊断
  • 血管病变诊断
  • 其他的

第 9 章：最终用户

  • 医院
  • 皮肤科诊所
  • 门诊手术中心
  • 研究实验室

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • Canfield Scientific, Inc
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售
      • 产品销售
    • 财务概览
      • 公司收入
      • 地域收入份额
      • 收入预测
    • 主要进展
      • 併购
      • 主要产品开发活动
      • 监管部门批准等
    • SWOT分析
  • FotoFinder Systems GmbH
  • 3Derm Systems, Inc.
  • HEINE Optotechnik GmbH & Co. KG
  • AMD Global Telemedicine, Inc.
  • Hill-Rom Holdings, Inc.
  • Derma Medical Systems
  • Leica Microsystems
  • Caliber ID (Formerly Lucid, Inc.)
  • GE Healthcare
  • Similar data will be provided for each market player.
  • VivaScope 有限公司
    • 管道产品说明
    • 产品关键绩效指标 (KPI)
    • 主要活动
    • 市场进入时间表
    • 产品渗透率
    • 销售估算与预测
  • 维里斯金公司
  • 视觉Dx
  • FotoFinder 中心
  • 远端皮肤
  • 将为每个市场参与者提供类似的资料。

第 12 章：附录

简介目录
Product Code: MD9062

The global diagnostic dermatology equipment market reached US$ 10.8 Billion in 2024 and is expected to reach US$ 22.4 Billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033.

The diagnostic dermatology equipment market is a crucial sector that uses various tools and technologies to identify, monitor, and evaluate skin conditions like skin cancer, psoriasis, eczema, and pigmentation disorders. these devices, like dermatoscopes, reflectance confocal microscopes, and optical coherence tomography, provide accurate, non-invasive, and early diagnosis, improving patient outcomes. the market is driven by technological advancements, such as ai integration and teledermatology solutions. the sector plays a critical role in dermatological care, bridging the gap between traditional methods and modern, digital, and ai-driven solutions.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Skin Disorders

The global market for diagnostic dermatology equipment is driven by the increasing prevalence of skin disorders like acne, psoriasis, eczema, and melanoma, which are becoming more prevalent due to factors like pollution, lifestyle changes, and prolonged sun exposure. The World Health Organization reports that skin diseases affect millions annually, leading to a demand for advanced diagnostic tools like dermatoscopes, imaging systems, and biopsy devices. The growing awareness of skin health and routine dermatological checkups further encourages the adoption of these devices, ensuring market growth.

For instance, according to American Academy of Dermatology Association, Acne is the most common skin condition in the US, affecting up to 50 million Americans annually. Different types of acne exist, making a one-size-fits-all approach unsuitable. A board-certified dermatologist can diagnose and determine the appropriate treatment based on the skin type and acne type. There are various treatments available, including oral, topical, over-the-counter, and prescription medications. Acne typically begins in puberty and affects adolescents and young adults, but can occur at any stage of life. Adult acne continues to increase, affecting up to 15% of women. Approximately 85% of people aged 12-24 experience minor acne.

High Cost of Diagnostic Dermatology Equipment

The high cost of diagnostic dermatology equipment, including dermatoscopes, confocal microscopes, and imaging systems, is a major obstacle to market growth, especially in low- and middle-income regions. These advanced tools are expensive upfront, making them less accessible to smaller clinics and healthcare facilities. Maintenance and operational expenses also add to the financial burden, further limiting their adoption. This issue is particularly problematic in areas with limited healthcare budgets or where dermatological services are not prioritized.

Segment Analysis

The global diagnostic dermatology equipment market is segmented based on product type, technology, Application, end user and region.

Product Type:

Imaging Devices segment is expected to dominate the Diagnostic Dermatology Equipment market share

The imaging devices segment holds a major portion of the diagnostic dermatology equipment market share and is expected to continue to hold a significant portion of the diagnostic dermatology equipment market share during the forecast period.

The imaging devices segment is a key player in the global diagnostic dermatology equipment market, offering accurate and non-invasive visualization of skin conditions. It includes devices like dermatoscopes, confocal microscopes, and multispectral imaging systems, which diagnose various dermatological disorders like melanoma, eczema, and psoriasis. These devices provide high-resolution images and advanced features like digital storage and AI-driven analytics. The growing prevalence of skin disorders and advancements in imaging technologies drive demand for these devices.

For instance, in June 2023, DeepX Diagnostics has received FDA clearance for its digital dermatoscope DermoSight, a tool for teledermatology screening of suspected skin cancer lesions in the US.

Hence, the FDA cleared DeepX Diagnostics' DermoSight digital dermatoscope in June 2023, indicating the growing use of advanced imaging tools in teledermatology, especially for skin cancer screening. This approval boosts the credibility and market potential of digital dermatoscopes, boosting healthcare provider trust and driving global imaging device growth.

End User:-

Hospitals segment is the fastest-growing segment in diagnostic dermatology equipment market share

The hospitals segment is the fastest-growing segment in the diagnostic dermatology equipment market share and is expected to hold the market share over the forecast period.

Hospitals are key players in the global diagnostic dermatology equipment market, focusing on diagnosing and managing complex conditions like melanoma, psoriasis, and eczema. They invest heavily in advanced diagnostic tools like imaging devices, biopsy systems, and AI-powered solutions to improve skin disease detection accuracy. Hospitals also adopt teledermatology platforms to enhance accessibility and patient outcomes. The rising prevalence of skin disorders and demand for specialized dermatological care are driving their contributions to market growth.

For instance, in January 2025, Lux Hospitals in Hyderabad has introduced the ENDOANAL Real-Time Ultrasound-Guided Laser Procedure for treating Fistula in Ano, pioneered by Dr. Samhitha Reddy Marpali. With over eight years of experience, Dr. Marpali specializes in treating various proctology disorders, including Piles, Fistulas, Anal Fissures, Pilonidal Sinus, Colon and Rectum Cancers, and other complex colorectal conditions. She offers world-class care to patients.

Geographical Analysis

North America is expected to hold a significant position in the Diagnostic Dermatology Equipment market share

North America holds a substantial position in the diagnostic dermatology equipment market and is expected to hold most of the market share due to due to its advanced healthcare infrastructure, FDA approvals, product launches, advanced technologies, increased awareness about early diagnosis and preventive dermatology, favorable reimbursement policies, key market players, and ongoing R&D initiatives, which contribute to its market leadership.

For instance, in June 2024, the US FDA has approved DermaSensor, the first AI-enabled medical device for skin cancer detection in primary care. This marks a new regulatory precedent for medical devices incorporating AI and ML technologies in dermatology. The device, already approved in the European Union and Australia, is considered a milestone in the industry, highlighting the clinical evidence and regulatory implications of AI-enabled technologies.

Europe is growing at the fastest pace in the Diagnostic Dermatology Equipment market

Europe holds the fastest pace in the diagnostic dermatology equipment market and is expected to hold most of the market share due to increasing incidence of skin diseases like atopic dermatitis and psoriasis, supported by government initiatives and public health campaigns. The aging population and well-established healthcare systems contribute to increased demand for advanced diagnostic tools. Investments in dermatology-focused research and development further support market expansion.

For instance, Eczema, also known as atopic dermatitis, is a prevalent skin disease in the UK, affecting 1 in 5 children and 1 in 10 adults. It is the leading contributor to skin-related disability, with severe cases more likely to develop depression. The disease burden is highest in disability-adjusted life-years (DALYs).

Hence, the disease contributes to skin-related disability and severe complications like depression, necessitating advanced diagnostic tools for early detection and effective management. The burden of disability-adjusted life-years underscores the need for accurate and efficient dermatological solutions, driving demand for innovative equipment in clinical and research settings.

Competitive Landscape

The major global players in the diagnostic dermatology equipment market include Canfield Scientific, Inc, FotoFinder Systems GmbH, 3Derm Systems, Inc, HEINE Optotechnik GmbH & Co. KG, AMD Global Telemedicine, Inc., Hill-Rom Holdings, Inc., Derma Medical Systems, Leica, Microsystems, Caliber I.D. (Formerly Lucid, Inc.), GE Healthcare and among others.

Key Developments

  • In October 2024, The American Academy of Dermatology is launched an initiative to highlight the debilitating condition of hidradenitis suppurativa (HS), a chronic progressive condition causing painful bumps in the armpits, thighs, and groin. HS is often misdiagnosed or undiagnosed, leading to scarring, pain, and impaired mobility. Patients with HS often suffer from depression, self-esteem issues, and daily living challenges, including work.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global diagnostic dermatology equipment market report delivers a detailed analysis with 70 key tables, more than 69 visually impactful figures, and 205 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Skin Disorders
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Diagnostic Dermatology Equipment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Imaging Devices*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Microscopy Devices
  • 6.4. Biopsy Devices
  • 6.5. Other Diagnostic Devices

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Digital Imaging*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. AI-Powered Diagnostic Tools
  • 7.4. Optical Imaging
  • 7.5. Molecular Imaging

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Skin Cancer Diagnosis*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Psoriasis Diagnosis
  • 8.4. Eczema Diagnosis
  • 8.5. Acne Diagnosis
  • 8.6. Pigmentation Disorders Diagnosis
  • 8.7. Vascular Lesions Diagnosis
  • 8.8. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Dermatology Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Research Laboratories

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

  • 12.1. Canfield Scientific, Inc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. FotoFinder Systems GmbH
  • 12.3. 3Derm Systems, Inc.
  • 12.4. HEINE Optotechnik GmbH & Co. KG
  • 12.5. AMD Global Telemedicine, Inc.
  • 12.6. Hill-Rom Holdings, Inc.
  • 12.7. Derma Medical Systems
  • 12.8. Leica Microsystems
  • 12.9. Caliber I.D. (Formerly Lucid, Inc.)
  • 12.10. GE Healthcare
  • Similar data will be provided for each market player.

Emerging Market Players

  • 12.11. VivaScope GmbH*
    • 12.11.1. Pipeline Products Description
    • 12.11.2. Product Key Performance Indicators (KPIs)
    • 12.11.3. Key Activities
    • 12.11.4. Market Entry Timelines
    • 12.11.5. Product Penetration Rate
    • 12.11.6. Sales Estimation and Projections
  • 12.12. Veriskin, Inc.
  • 12.13. VisualDx
  • 12.14. FotoFinder Hub
  • 12.15. TeleSkin
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us